Wolf‐K. Hofmann

2.1k total citations
25 papers, 1.7k citations indexed

About

Wolf‐K. Hofmann is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Wolf‐K. Hofmann has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Wolf‐K. Hofmann's work include Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Wolf‐K. Hofmann is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Wolf‐K. Hofmann collaborates with scholars based in Germany, United States and Austria. Wolf‐K. Hofmann's co-authors include H. Phillip Koeffler, Dieter Hoelzer, Sven de Vos, Martina Komor, William Wachsman, Adrian F. Gombart, Utz Krug, Carl W. Miller, Seisho Takeuchi and Oliver G. Ottmann and has published in prestigious journals such as The Journal of Cell Biology, Blood and Oncogene.

In The Last Decade

Wolf‐K. Hofmann

25 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolf‐K. Hofmann Germany 18 770 763 376 278 204 25 1.7k
Kenneth S. Zuckerman United States 24 598 0.8× 469 0.6× 330 0.9× 318 1.1× 343 1.7× 67 1.5k
F. Brok‐Simoni Israel 21 584 0.8× 362 0.5× 286 0.8× 203 0.7× 168 0.8× 70 1.4k
Weston P. Miller United States 25 814 1.1× 373 0.5× 223 0.6× 199 0.7× 255 1.3× 72 1.7k
Jonathan M. Gerber United States 19 813 1.1× 424 0.6× 168 0.4× 384 1.4× 187 0.9× 57 1.7k
JW Lee South Korea 21 542 0.7× 701 0.9× 158 0.4× 256 0.9× 204 1.0× 56 1.8k
Jean Gabert France 18 352 0.5× 568 0.7× 201 0.5× 207 0.7× 316 1.5× 51 1.4k
Christina Halsey United Kingdom 19 599 0.8× 352 0.5× 239 0.6× 238 0.9× 176 0.9× 36 1.3k
Takashi Machii Japan 25 621 0.8× 546 0.7× 427 1.1× 334 1.2× 760 3.7× 86 2.1k
Simonetta Rizzi Italy 21 362 0.5× 848 1.1× 185 0.5× 359 1.3× 334 1.6× 77 1.4k

Countries citing papers authored by Wolf‐K. Hofmann

Since Specialization
Citations

This map shows the geographic impact of Wolf‐K. Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolf‐K. Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolf‐K. Hofmann more than expected).

Fields of papers citing papers by Wolf‐K. Hofmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolf‐K. Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolf‐K. Hofmann. The network helps show where Wolf‐K. Hofmann may publish in the future.

Co-authorship network of co-authors of Wolf‐K. Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Wolf‐K. Hofmann. A scholar is included among the top collaborators of Wolf‐K. Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolf‐K. Hofmann. Wolf‐K. Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nittka, Stefanie, Christine H. Lorenz, Constanze Rémi, et al.. (2024). Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study). BMC Palliative Care. 23(1). 8–8. 1 indexed citations
2.
Nolte, Florian, Christiane Schumann, Stefan Klein, Mark Reinwald, & Wolf‐K. Hofmann. (2012). Characteristics of MDS patients seen at private practices differ significantly from those treated at university hospitals in Germany. Journal of Cancer Research and Clinical Oncology. 138(6). 953–957. 2 indexed citations
3.
Nolte, Florian, Emanuele Angelucci, Photis Beris, et al.. (2011). Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox. Leukemia Research. 35(9). 1131–1135. 12 indexed citations
4.
5.
Hütter, Gero, Susanne Ganepola, & Wolf‐K. Hofmann. (2008). The hematology of anorexia nervosa. International Journal of Eating Disorders. 42(4). 293–300. 91 indexed citations
6.
Gery, Sigal, Dorothy J. Park, Peter T. Vuong, et al.. (2007). RTP801 is a novel retinoic acid–responsive gene associated with myeloid differentiation. Experimental Hematology. 35(4). 572–578. 26 indexed citations
7.
Gery, Sigal, Sakae Tanosaki, Wolf‐K. Hofmann, Ahrin Koppel, & H. Phillip Koeffler. (2005). C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation. Oncogene. 24(9). 1589–1597. 57 indexed citations
8.
Jones, Letetia C., Ayalew Tefferi, Peter T. Vuong, et al.. (2005). Detection of Aberrant Gene Expression in CD34 + Hematopoietic Stem Cells from Patients with Agnogenic Myeloid Metaplasia Using Oligonucleotide Microarrays. Stem Cells. 23(5). 631–637. 13 indexed citations
9.
Hofmann, Wolf‐K. & H. Phillip Koeffler. (2005). Myelodysplastic Syndrome. Annual Review of Medicine. 56(1). 1–16. 86 indexed citations
10.
Hofmann, Wolf‐K., Claudia D. Baldus, Lutz Uharek, & Eckhard Thiel. (2004). Therapeutic spectrum in the treatment of myelodysplastic syndromes. Expert Opinion on Pharmacotherapy. 5(12). 2451–2458. 2 indexed citations
11.
Koli, Katri, Frank Wempe, Anja Sterner‐Kock, et al.. (2004). Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung. The Journal of Cell Biology. 167(1). 123–133. 60 indexed citations
12.
Rummel, Mathias, Sven de Vos, Dieter Hoelzer, H. Phillip Koeffler, & Wolf‐K. Hofmann. (2003). Altered Apoptosis Pathways in Mantle Cell Lymphoma. Leukemia & lymphoma. 45(1). 49–54. 26 indexed citations
13.
Hofmann, Wolf‐K., Martina Komor, Dieter Hoelzer, & Oliver G. Ottmann. (2003). Mechanisms of Resistance to STI571 (Imatinib) in Philadelphia-chromosome Positive Acute Lymphoblastic Leukemia. Leukemia & lymphoma. 45(4). 655–660. 40 indexed citations
14.
Vegesna, Vijaya, Seisho Takeuchi, Wolf‐K. Hofmann, et al.. (2002). C/EBP-β, C/EBP-δ, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies. Leukemia Research. 26(5). 451–457. 48 indexed citations
15.
Hofmann, Wolf‐K., Sven de Vos, Martina Komor, et al.. (2002). Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood. 100(10). 3553–3560. 179 indexed citations
16.
Hofmann, Wolf‐K., Xiangjun Tong, Richard S. Ajioka, James P. Kushner, & H. Phillip Koeffler. (2002). Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis. Blood. 100(3). 1099–1100. 23 indexed citations
17.
Hofmann, Wolf‐K., Sven de Vos, Kunihiro Tsukasaki, et al.. (2001). Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood. 98(3). 787–794. 150 indexed citations
18.
Hofmann, Wolf‐K., Carl W. Miller, Kunihiro Tsukasaki, et al.. (2001). Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias. Leukemia Research. 25(4). 333–338. 52 indexed citations
19.
Miller, Carl W., Takayuki Ikezoe, Utz Krug, et al.. (2001). Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors. Genes Chromosomes and Cancer. 33(1). 17–21. 77 indexed citations
20.
Hofmann, Wolf‐K., Seisho Takeuchi, Dong Xie, et al.. (2001). Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes. Leukemia Research. 25(10). 855–858. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth S. Zuckerman Breakdown of academic impact, for papers by F. Brok‐Simoni Breakdown of academic impact, for papers by Weston P. Miller Breakdown of academic impact, for papers by Jonathan M. Gerber Breakdown of academic impact, for papers by JW Lee Breakdown of academic impact, for papers by Jean Gabert Breakdown of academic impact, for papers by Christina Halsey Breakdown of academic impact, for papers by Takashi Machii Breakdown of academic impact, for papers by Simonetta Rizzi
Rankless by CCL
2026